Taken together these studies indicate that increased PGE2/EP4 signaling promote the tumor and mesenchymal activities of CD44+/CD24- breast CSCs; however, any corresponding effect on the more epithelial-like ALDH+ CSCs was not specifically assessed in the studies. The gene discussed is LDHA; the disease is neoplasm.